# OnCo record itm-11 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/itm-11/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "itm-11" ;
  schema:name "177Lu-edotreotide"@en ;
  schema:description "A second lutetium radioligand for neuroendocrine tumours that beat the standard pill everolimus in a head-to-head trial and is awaiting an FDA decision."@en ;
  schema:url <https://onco.cc/drugs/itm-11/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03049189> ;
  onco:status "phase-3" ;
  onco:modality "Radioligand therapy (beta)" ;
  onco:cancers <https://onco.cc/cancers/neuroendocrine/>, <https://onco.cc/cancers/grade-3-net/> ;
  onco:technologies <https://onco.cc/technologies/prrt/>, <https://onco.cc/technologies/radioligand-therapy/> ;
  onco:targets <https://onco.cc/targets/sstr2/> ;
  onco:companies <https://onco.cc/companies/itm/> ;
  onco:trials <https://onco.cc/trials/compete/>, <https://onco.cc/trials/nct04919226/> .